Schedule 13G ownership disclosure

Capstone Therapeutics Corp.

Security class unavailable · CUSIP: 14068E109

Event date: 2018-01-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,657,422
Percent of class
14.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-003268
Form type
SC 13G
Filer
Capstone Holding Corp.
CIK
CIK 887151
Filed
Jan 23, 2018
Reporting period
Jan 12, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G | SEC Filings Hub